Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • PI3K
    (353)
  • Apoptosis
    (111)
  • mTOR
    (85)
  • Akt
    (77)
  • Autophagy
    (61)
  • DNA-PK
    (31)
  • NF-κB
    (24)
  • ERK
    (12)
  • p38 MAPK
    (11)
  • Others
    (160)
Filter
Search Result
Results for "

pi3k

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    660
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    6
    TargetMol | Compound_Libraries
  • Peptide Products
    12
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
  • PROTAC Products
    4
    TargetMol | PROTAC
  • Natural Products
    144
    TargetMol | Natural_Products
  • Recombinant Protein
    18
    TargetMol | Recombinant_Protein
  • Isotope Products
    3
    TargetMol | Isotope_Products
  • Antibody Products
    22
    TargetMol | Antibody_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
  • Cell Research
    2
    TargetMol | Inhibitors_Agonists
PI3K/Akt/mTOR-IN-2
T605642757804-89-8In house
PI3K Akt mTOR-IN-2 is a potent PI3K AKT mTOR inhibitor with anticancer effects and selectivity for MDA-MB-231 cells (IC50 2.29 μM). It induces cell cycle arrest and apoptosis in cancer cells.
  • $33
In Stock
Size
QTY
LY294002
SF 1101, NSC 697286, LY 294002
T2008154447-36-6
LY294002 (SF 1101) is a broad-spectrum inhibitor of PI3K, inhibiting PI3Kα, PI3Kδ, and PI3Kβ (IC50=0.5/0.57/0.97 μM). LY294002 is also an inhibitor of DNA-PK (IC50=1.4 μM) and an inhibitor of CK2 (IC50=98 nM). LY294002 activates apoptosis and autophagy.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Quercetin
Sophoretin
T2174117-39-5
Quercetin, a flavonoid natural product, is a SIRT1 activator. It is also a PI3K inhibitor, inhibiting PI3Kγ, PI3Kδ, and PI3Kβ with IC50 values of 2.4, 3.0, and 5.4 μM, respectively. Recognized as a heat shock protein inhibitor, Quercetin can significantly reduce exosome release in TII models by downregulating Hsp70 or Hsp90.
  • $42
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Recilisib
ON 01210, Ex-RAD
T13862334969-03-8
Recilisib (ON 01210) is a radioprotectant that activates AKT and PI3K activities in cells.
  • $38
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Inavolisib
RG6114, GDC-0077
T153752060571-02-8
Inavolisib (GDC-0077) is an orally available selective PI3Kα inhibitor with an IC50 value of 0.038 nM.It exerts its activity by binding to the ATP-binding site of PI3K, thereby inhibiting the phosphorylation of PIP2 to PIP3.
  • $80
In Stock
Size
QTY
TargetMol | Inhibitor Hot
3-Methyladenine
NSC 66389, 3-MA
T18795142-23-4
3-Methyladenine (3-MA) is a PI3K inhibitor that selectively inhibits class IB PI3Kγ (IC50 = 60 μM) and class III VPS34 (IC50 = 25 μM). 3-Methyladenine inhibits autophagy.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Duvelisib (R enantiomer) hydrochloride
IPI-145 R enantiomer HCl, INK1197 R enantiomer HCl, Duvelisib (R enantiomer) hydrochloride(1261590-48-0 Free base)
T11129L In house
Duvelisib (R enantiomer) hydrochloride (INK1197 R enantiomer HCl) is a PI3K inhibitor. Duvelisib (R enantiomer) hydrochloride is the less active enantiomer of Duvelisib.
  • $329
In Stock
Size
QTY
Duvelisib
IPI-145, INK1197
T19881201438-56-3In house
Duvelisib (INK1197, IPI-145) is a selective inhibitor of phosphatidylinositol 3-kinase (PI3K) and p100δ, with effects on p110δ (IC50 value is 0.0025 μM), p110γ (IC50 value is 0.274 μM), p110β (IC50 value is 0.85 μM) and p110α (IC50 value is 1.602 μM).
  • $40
In Stock
Size
QTY
Protectin D1
NPD1, Neuroprotectin D1
T37379660430-03-5In house
Protectin D1 (Neuroprotectin D1) is a neuroprotectin produced by neuronal cells and is a potential cardioprotective agent.Protectin D1 attenuates myocardial ischemia reperfusion injury and inhibits imiquimod-induced psoriasis-like skin inflammation by modulating the PI3K AKT signaling pathway.
  • $245
In Stock
Size
QTY
BGT226
NVP-BGT226, BGT226 free base
T6072L915020-55-2In house
BGT226 (NVP-BGT226) is a novel dual PI3K/mTOR inhibitor, targeting PI3K α, β, and γ with IC50 values of 4 nM, 63 nM, and 38 nM, respectively.
  • $44
In Stock
Size
QTY
Torbafylline
T67965105102-21-4In house
Torbafylline, a xanthine derivative, is a phosphodiesterase (PDE) inhibitor that attenuates burn-induced protein hydrolysis in rat skeletal muscle through activation of the PDE4/cAMP/EPAC/PI3K/Akt pathway, and inhibits the enhanced ubiquitin-proteasome-dependent protein hydrolysis in skeletal muscle of cancer- and sepsis-prone rats.
  • $130
In Stock
Size
QTY
gsk2292767
T68501254036-66-2In house
GSK2292767 is a potent and selective inhibitor of PI3Kδ.
  • $159
35 days
Size
QTY
PQR514
T700581927857-55-3In house
PQR514 is a potent PI3K inhibitor with anticancer activity and inhibits cancer cell proliferation.
  • $333 TargetMol
In Stock
Size
QTY
Safingol hydrochloride
SPC 100270 hydrochloride, L-threo-dihydrosphingosine hydrochloride
T83978139755-79-6In house
Safingol hydrochloride (L-threo-dihydrosphingosine hydrochloride) is a specific inhibitor of protein kinase C. It induces autophagy in solid tumor cells and cancer cell death by inhibiting the PKC and PI3-kinase pathways.BIIB 722 Mesylate is a selective sodium-hydrogen exchange inhibitor. Safingol hydrochloride inhibits PKC and PI3k.
  • $195 TargetMol
In Stock
Size
QTY
iMDK
T9460881970-80-5In house
iMDK quarterhydrate is a potent PI3K inhibitor that inhibits the growth factor MDK (also known as midkine or MK). iMDK quarterhydrate synergistically inhibits non-small cell lung cancer (NSCLC) with MEK inhibitors without harming normal cells and mice.
  • $54
In Stock
Size
QTY
Isoprenaline hydrochloride
NCI-c55630, Isoproterenol hydrochloride, Isoprenaline HCl
T105651-30-9
Isoprenaline hydrochloride (NCI-c55630) is a potent beta-adrenergic agonist with the peripheral vasodilator, bronchodilator, and cardiac stimulating properties.
  • $33
In Stock
Size
QTY
Idelalisib
GS-1101, CAL-101
T1894870281-82-6
Idelalisib (GS-1101) is a small molecule inhibitor of the PI3K catalytic subunit p110δ (IC50: 2.5 nM). The selectivity for p110δ is 40- to 300-fold than p110α/β/γ.
  • $30
In Stock
Size
QTY
Alpelisib
BYL-719
T19211217486-61-7
Alpelisib (BYL-719) is a PI3Kα inhibitor (IC50=5 nM) with selective, potent, and oral activity, inhibiting PI3Kβ γ δ with low activity (IC50=250 290 1200 nM). Alpelisib demonstrates antitumor activity and specifically targets PIK3CA mutant tumors.
  • $33
In Stock
Size
QTY
CNX-1351
T22561276105-89-5
CNX-1351 is a potent, isoform-selective, and targeted covalent inhibitor of PI3Kα.
  • $41
In Stock
Size
QTY
Sophocarpine monohydrate
Sophocarpine hydrate
T2746145572-44-7
Sophocarpine monohydrate, a major ingredient of Sophora alopecuroides, has a wide range of pharmacological effects.
  • $50
In Stock
Size
QTY
Esculetin
Cichorigenin, Aesculetin
T2798305-01-1
Esculetin (Cichorigenin) is a coumarin derivative from various natural plant products with various biological and pharmaceutical properties including anti-edema, anti-inflammatory and anti-tumour effects. It inhibits lipoxygenases (LOs).
  • $45
In Stock
Size
QTY
1-Deoxynojirimycin
Moranoline, moranolin, Duvoglustat
T367519130-96-2
1-Deoxynojirimycin (Moranoline) is a potent α-glucosidase inhibitor, suppressing postprandial blood glucose, thereby possibly preventing diabetes mellitus.
  • $38
In Stock
Size
QTY
α-Linolenic acid
Linolenic acid, Alpha-Linolenic Acid
T3P2904463-40-1
α-Linolenic Acid (ALA) is an essential fatty acid that cannot be synthesized by the human body and is obtained by isolating it from seed oils. α-Linolenic acid has been shown to improve memory, inhibit thrombosis, and lower blood lipids.
  • $33
In Stock
Size
QTY
Erucic acid
Prifac 2990, cis-13-docosenoic acid, 13(Z)-Docosenoic Acid
T4867112-86-7
Increased levels of erucic acid (22:1n9) have been found in the red blood cell membranes of autistic subjects with developmental regression (PMID: 16581239 ). Erucic acid (13(Z)-Docosenoic Acid) is broken down long-chain acyl-coenzyme A (CoA) dehydrogenase, which is produced in the liver. This enzyme breaks this long chain fatty acid into shorter-chain fatty acids. human infants have relatively low amounts of this enzyme and because of this, babies should not be given foods high in erucic acid. Erucic acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism.
  • $33
In Stock
Size
QTY